Medication info
Exforge 10/160 mg (Amlodipine Besilate, Valsartan)

Exforge 10/160 mg (Amlodipine Besilate, Valsartan)

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Novartis Korea Ltd.
Appearance
Bright yellow oval film-coated tablet
Packaging
28 tablets (14 tablets/PTP packaging X 2), 28 tablets (7 tablets/PTP packaging X 4)
Approval status
Active

MFDS item code 200703805 · Approved 2007.04.03 · Insurance code 653600840

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before administering this medicine. However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients 65 years of age or older: Exercise caution when increasing the dose.
Child dose
Pediatric patients younger than 18 years: The safety and efficacy have not been established; therefore, use of this medicine is not recommended.

Ingredients

Importer
Novartis Korea Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension where blood pressure is not adequately controlled by monotherapy with either amlodipine or valsartan. It assists in effectively improving blood pressure when control is difficult with current treatments.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before administering this medicine. However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients 65 years of age or older: Exercise caution when increasing the dose.

Child dose

Pediatric patients younger than 18 years: The safety and efficacy have not been established; therefore, use of this medicine is not recommended.

Precautions

This medicine can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; thus, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this medication, pregnant or breastfeeding women, patients with severe kidney or liver dysfunction, and those with a history of certain heart conditions or angioedema should not take this medication. Special caution is needed for patients with body sodium or fluid depletion, hyperkalemia, renal artery stenosis, recent kidney transplant, heart failure, or myocardial infarction; these patients require close observation by a physician while taking this medication. Various side effects such as headache, dizziness, edema, hypotension, cough, dyspepsia, skin rash might occur during treatment, so immediate consultation with healthcare providers is necessary if unusual symptoms appear. Caution is advised while driving or operating machinery as dizziness or fatigue may occur. This medication may interact with other antihypertensives, potassium supplements, diuretics, certain anti-inflammatory drugs, lithium preparations, etc., so if you are on any other medications, you must inform your doctor or pharmacist. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women are also advised to avoid it. This medication is not recommended for children under 18 years of age, as safety and efficacy have not been sufficiently established.

Side effects

Nasopharyngitis, Influenza, Hypersensitivity, Vision impairment, Anxiety, Headache, Dizziness, Drowsiness, Position-related dizziness, Paresthesia, Vertigo, Tinnitus, Tachycardia, Palpitations, Syncope, Orthostatic hypotension, Hypotension, Cough, Pharyngeal and laryngeal pain, Diarrhea, Nausea, Abdominal pain, Constipation, Thirst, Rash, Erythema, Hyperhidrosis, Itching, Joint swelling, Low back pain, Arthritis, Muscle cramps, Lethargy, Polyuria, Nocturia, Erectile dysfunction, Edema, Ankle edema, Facial edema, Peripheral edema, Fatigue, Flushing, Asthenia, Facial flushing, Decreased hemoglobin, Decreased hematocrit, Neutropenia, Thrombocytopenia, hypersensitivity including serum sickness, Increased serum potassium, Vasculitis, Elevated liver function tests, Angioedema, Bullous dermatitis, Myalgia, Renal failure, Kidney damage, Increased serum creatinine, Insomnia, Decreased libido, Pharyngitis, Rhinitis, Sinusitis, Upper respiratory infection, Viral infection, Diplopia, Thrombocytopenia, Leukopenia, Allergic reaction, Hyperglycemia, Insomnia, Emotional changes, Tremor, Sensory reduction, Dysgeusia, Peripheral neuropathy, Hypertonicity, Arrhythmia, Bradycardia, Atrial fibrillation, Ventricular tachycardia, Myocardial infarction, Vasculitis, Dyspnea, Rhinitis, Vomiting, Dyspepsia, Pancreatitis, Gastritis, Gingival hyperplasia, Hepatitis, Jaundice, Alopecia, Purpura, Skin depigmentation, Photosensitivity reaction, Angioedema, Urticaria, Erythema multiforme, Stevens-Johnson syndrome, Myalgia, Urinary disorders, Nocturnal enuresis, Gynecomastia, Pain, Apathy, Chest pain, Weight loss, Weight gain, Increased liver enzymes, Chest discomfort, Abdominal discomfort, Gastroesophageal reflux, Neck pain, Hypercholesterolemia, Hypoglycemia, Neuroirritability, Sensory reduction, Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

Keep this medication in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. Storing it this way will ensure the effectiveness of the medication.

Appearance and packaging

Appearance

Bright yellow oval film-coated tablet

Package unit

28 tablets (14 tablets/PTP packaging X 2), 28 tablets (7 tablets/PTP packaging X 4)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.